The need for coronary artery surgery: expand or restrict? A European view

M E Rothlin1

  • 1University Hospital, Zürich, Switzerland.

European Heart Journal
|September 1, 1987
PubMed

Insights

Aorto-coronary bypass surgery indications are debated, particularly regarding angina severity and risk factors. Despite controversies, the number of these bypass operations is rising across Europe, suggesting an expansion of its use.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Health Economics

Background:

  • Established consensus exists on the importance of angina pectoris and prognostic factors for aorto-coronary bypass indications.
  • Significant controversy persists regarding the precise thresholds for angina severity and risk factor profiles necessitating surgical intervention.

Purpose of the Study:

  • To comment on controversial issues surrounding the indications for aorto-coronary bypass surgery.
  • To discuss the evolving role of mechanical revascularization techniques compared to traditional bypass surgery.
  • To highlight the increasing use of cost-benefit analyses in surgical decision-making.

Main Methods:

  • Review and commentary on existing medical literature and clinical practice regarding aorto-coronary bypass indications.
  • Analysis of trends in the utilization of aorto-coronary bypass operations across European countries.
  • Consideration of the potential impact of alternative revascularization methods like balloon dilatation.

Main Results:

  • While consensus exists on general indications, specific criteria for angina severity and risk factors remain debated.
  • The number of aorto-coronary bypass operations shows a consistent upward trend throughout Europe.
  • Cost-benefit analyses are increasingly influencing medical decisions and policy-making in cardiovascular interventions.

Conclusions:

  • The current trends suggest an expansion in the application of aorto-coronary bypass surgery.
  • Further research is needed to clarify optimal indications and the comparative effectiveness of alternative revascularization strategies.
  • Integrating economic evaluations is crucial for informed decision-making in cardiovascular procedures.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...